BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15336472)

  • 1. Retrospective longitudinal cohort study comparing the effects of angiotensin-converting enzyme inhibitors and long-acting calcium channel blockers on total and cardiovascular mortality in patients with hypertension.
    Tardif JC; Ducharme A; Yu H; Wogen J; Guertin MC
    Clin Ther; 2004 Jul; 26(7):1073-83. PubMed ID: 15336472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.
    L'Allier PL; Ducharme A; Keller PF; Yu H; Guertin MC; Tardif JC
    J Am Coll Cardiol; 2004 Jul; 44(1):159-64. PubMed ID: 15234426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
    Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
    Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed-Dose Combinations of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors.
    Hsiao FC; Tung YC; Chou SH; Wu LS; Lin CP; Wang CL; Lin YS; Chang CJ; Chu PH
    Medicine (Baltimore); 2015 Dec; 94(51):e2355. PubMed ID: 26705234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
    Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality and Morbidity Among Individuals With Hypertension Receiving a Diuretic, ACE Inhibitor, or Calcium Channel Blocker: A Secondary Analysis of a Randomized Clinical Trial.
    Yamal JM; Martinez J; Osani MC; Du XL; Simpson LM; Davis BR
    JAMA Netw Open; 2023 Dec; 6(12):e2344998. PubMed ID: 38048133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
    Bulpitt CJ; Palmer AJ; Beevers DG; Coles EC; Ledingham JG; Petrie JC; Webster J
    J Hum Hypertens; 1997 Apr; 11(4):205-11. PubMed ID: 9185024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care.
    Haroon S; Subramanian A; Cooper J; Anand A; Gokhale K; Byne N; Dhalla S; Acosta-Mena D; Taverner T; Okoth K; Wang J; Chandan JS; Sainsbury C; Zemedikun DT; Thomas GN; Parekh D; Marshall T; Sapey E; Adderley NJ; Nirantharakumar K
    BMC Infect Dis; 2021 Mar; 21(1):262. PubMed ID: 33722197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker.
    Okano GJ; Rascati KL; Wilson JP; Remund DD; Grabenstein JD; Brixner DI
    Clin Ther; 1997; 19(6):1433-45; discussion 1424-5. PubMed ID: 9444451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [One-year persistence of fixed-dose combinations of angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertensive patients].
    Simonyi G; Ferenci T; Finta E; Igaz I; Balogh S; Gasparics R; Medvegy M
    Orv Hetil; 2019 Mar; 160(9):343-348. PubMed ID: 30798621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting.
    Sapienza S; Sacco P; Floyd K; DiCesare J; Doan QD
    Clin Ther; 2003 Jun; 25(6):1872-87. PubMed ID: 12860503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARB users exhibit a lower fracture incidence than ACE inhibitor users among older hypertensive men.
    Kwok T; Leung J; Barrett-Connor E;
    Age Ageing; 2017 Jan; 46(1):57-64. PubMed ID: 28181652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnitude of and Characteristics Associated With the Treatment of Calcium Channel Blocker-Induced Lower-Extremity Edema With Loop Diuretics.
    Vouri SM; Jiang X; Manini TM; Solberg LM; Pepine C; Malone DC; Winterstein AG
    JAMA Netw Open; 2019 Dec; 2(12):e1918425. PubMed ID: 31880802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of antihypertensive drugs and drug combinations on the incidence of new-onset type-2 diabetes mellitus.
    Burke TA; Sturkenboom MC; Ohman-Strickland PA; Wentworth CE; Rhoads GG
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):979-87. PubMed ID: 17605137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011.
    Gitsels LA; Kulinskaya E; Steel N
    BMJ Open; 2017 Jan; 7(1):e013570. PubMed ID: 28119386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [One-year persistence of renin-angiotensin-aldosterone system inhibitors fixed drug combinations in hypertensive patients].
    Simonyi G; Ferenci T; Finta E; Medvegy M; Wittmann I
    Orv Hetil; 2023 Aug; 164(34):1337-1341. PubMed ID: 37634155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
    Tsai MS; Tang CH; Lin CY; Chuang PY; Chen NC; Huang CH; Chang WT; Wang TD; Yu PH; Chen WJ
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):535-543. PubMed ID: 29218625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel blockers in hypertension: reappraisal after new trials and major meta-analyses.
    Opie LH
    Am J Hypertens; 2001 Oct; 14(10):1074-81. PubMed ID: 11710789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.